Newark Wayne Community Hospital-Lab
Newark Wayne Community Hospital-Lab was paid $1.61M by Medicaid between May 2019 and Dec 2024, across 29 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 25% of everything it billed.
NEWARK, NY 14513
Next to other Clinical Medical Laboratory providers in New York
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 648 | $16K | |
| 2020 | 2,054 | $57K | |
| 2021 | 12,088 | $404K | |
| 2022 | 14,944 | $580K | |
| 2023 | 11,430 | $337K | |
| 2024incomplete | 7,989 | $217K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 25% | 5,336 | 5,154 | $399K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 15% | 3,175 | 3,122 | $238K |
| 87631 | 10% | 1,496 | 1,472 | $165K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 8.3% | 4,326 | 4,284 | $134K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 8.3% | 4,327 | 4,286 | $134K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 8.1% | 5,246 | 5,066 | $131K |
| 87634 | 4.6% | 1,353 | 1,337 | $74K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 3.7% | 1,346 | 1,324 | $60K |
| 87480 | 3.1% | 2,858 | 2,810 | $50K | |
| 87510 | 3.1% | 2,823 | 2,775 | $50K | |
| 87660 | 3.1% | 2,822 | 2,774 | $50K | |
| 87081 | 2.7% | 7,436 | 7,240 | $44K |
17 more codes
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.2% | 2,768 | $20K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.1% | 216 | $18K |
| 88142 | 1.0% | 609 | $16K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 354 | $11K |
| 87186 | <1% | 566 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 314 | $2K |
| 80053 | Comprehensive metabolic panel | <1% | 211 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 286 | $2K |
| 81001 | <1% | 685 | $2K | |
| 87077 | <1% | 189 | $2K | |
| 87150 | <1% | 51 | $2K | |
| 87088 | <1% | 183 | $1K | |
| 87070 | <1% | 126 | $963.93 | |
| 87641 | <1% | 12 | $371.16 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 12 | $359.76 |
| 82565 | <1% | 13 | $58.76 | |
| 84132 | <1% | 14 | $56.70 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.